4SCAR19U
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 24, 2026
4SCAR19U T Cells Targeting B Cell Malignancies
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Dec 2026 ➔ Dec 2030 | Trial primary completion date: Sep 2026 ➔ Dec 2029
Trial completion date • Trial primary completion date • Oncology • CD19
August 16, 2023
4SCAR19U T Cells Targeting B Cell Malignancies
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute
New P1 trial • Oncology • CD19
1 to 2
Of
2
Go to page
1